Market Overview:
The global cardiac mapping market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of cardiovascular diseases, technological advancements in cardiac mapping systems, and rising demand for minimally invasive procedures. The contact cardiac mapping systems segment is expected to dominate the global cardiac mapping market during the forecast period. This segment is anticipated to grow at a CAGR of 7.8% from 2018 to 2030 owing to its advantages such as high accuracy and precision, ability to map complex arrhythmias, and real-time visualization capabilities. The atrial fibrillation application segment is projectedto grow at a CAGR of 8% from 2018to 2030 due toprevalenceof this condition across the globeandthe increasing adoption oftreatment options such as catheter ablation therapy.
Product Definition:
A cardiac mapping procedure is a test that is used to help doctors find and track the electrical activity of your heart. This test can help your doctor find problems with your heart's electrical system.
Contact Cardiac mapping systems:
The global contact cardiac mapping systems, it's usage and growth factor in the Cardiac Mapping market is a study of the development, by IGI, Inc. It provides complete insights about current trends and future forecasts for key regional markets across North America, Europe, Asia Pacific and RoW.
Non-contact Cardiac mapping systems:
Non-contact cardiac mapping systems are used to measure and record the electrical activity of the heart without making any contact with it. These devices include electrocardiograph, EKG, electrophysiology, and echocardiography equipment.
Application Insights:
The atrial fibrillation segment dominated the global market in 2017 and is expected to register the fastest CAGR over the forecast period. The growing incidence of atrial fibrillation, which results in blood flow through an irregular pathway in the heart, is one of the major factors driving growth. According to a study published by NCBI, it was found that around 5% of people aged between 60 and 74 years have this condition while around 12% among those above 75 years have experienced some form of Atrial Fibrillation (AF).
In addition, technological advancements such as introduction of advanced imaging techniques for mapping cardiac structures are also expected to boost growth during future phases. For instance, Mapping Cardiac Arrhythmias with Non-invasive Electrocardiography (NEC) using Computed Tomography Angiography (CTA) has enabled physicians to visualise complex anatomic structures better than ever before.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the increasing prevalence of atrial fibrillation (AF), which is one of the major causes of disability and death in North America. According to a study published by JAMA, around 6.3 million people were diagnosed with AF in 2015 and it was estimated that around 895,000 people died due to this condition each year in U.S., making it as one of the top three causes for mortality among all other diseases.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising demand for minimally invasive procedures
- Technological advancements in cardiac mapping devices
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiac Mapping Market Research Report
By Type
Contact Cardiac mapping systems, Non-contact Cardiac mapping systems
By Application
Atrial Fibrillation, Atrial Flutter, AVNRT, Other Arrhythmias
By Companies
Biosense Webster, Abbott, Boston Scientific Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
160
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Cardiac Mapping Market Report Segments:
The global Cardiac Mapping market is segmented on the basis of:
Types
Contact Cardiac mapping systems, Non-contact Cardiac mapping systems
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Atrial Fibrillation, Atrial Flutter, AVNRT, Other Arrhythmias
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biosense Webster
- Abbott
- Boston Scientific Corporation
Highlights of The Cardiac Mapping Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Contact Cardiac mapping systems
- Non-contact Cardiac mapping systems
- By Application:
- Atrial Fibrillation
- Atrial Flutter
- AVNRT
- Other Arrhythmias
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiac Mapping Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cardiac mapping is a procedure that uses imaging technology to create detailed images of the heart. Cardiac mapping can help doctors diagnose and treat heart conditions.
Some of the key players operating in the cardiac mapping market are Biosense Webster, Abbott, Boston Scientific Corporation.
The cardiac mapping market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiac Mapping Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiac Mapping Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiac Mapping Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiac Mapping Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiac Mapping Market Size & Forecast, 2018-2028
4.5.1 Cardiac Mapping Market Size and Y-o-Y Growth
4.5.2 Cardiac Mapping Market Absolute $ Opportunity
Chapter 5 Global Cardiac Mapping Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cardiac Mapping Market Size Forecast by Type
5.2.1 Contact Cardiac mapping systems
5.2.2 Non-contact Cardiac mapping systems
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cardiac Mapping Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cardiac Mapping Market Size Forecast by Applications
6.2.1 Atrial Fibrillation
6.2.2 Atrial Flutter
6.2.3 AVNRT
6.2.4 Other Arrhythmias
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiac Mapping Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiac Mapping Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cardiac Mapping Analysis and Forecast
9.1 Introduction
9.2 North America Cardiac Mapping Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cardiac Mapping Market Size Forecast by Type
9.6.1 Contact Cardiac mapping systems
9.6.2 Non-contact Cardiac mapping systems
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cardiac Mapping Market Size Forecast by Applications
9.10.1 Atrial Fibrillation
9.10.2 Atrial Flutter
9.10.3 AVNRT
9.10.4 Other Arrhythmias
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cardiac Mapping Analysis and Forecast
10.1 Introduction
10.2 Europe Cardiac Mapping Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cardiac Mapping Market Size Forecast by Type
10.6.1 Contact Cardiac mapping systems
10.6.2 Non-contact Cardiac mapping systems
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cardiac Mapping Market Size Forecast by Applications
10.10.1 Atrial Fibrillation
10.10.2 Atrial Flutter
10.10.3 AVNRT
10.10.4 Other Arrhythmias
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cardiac Mapping Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cardiac Mapping Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cardiac Mapping Market Size Forecast by Type
11.6.1 Contact Cardiac mapping systems
11.6.2 Non-contact Cardiac mapping systems
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cardiac Mapping Market Size Forecast by Applications
11.10.1 Atrial Fibrillation
11.10.2 Atrial Flutter
11.10.3 AVNRT
11.10.4 Other Arrhythmias
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cardiac Mapping Analysis and Forecast
12.1 Introduction
12.2 Latin America Cardiac Mapping Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cardiac Mapping Market Size Forecast by Type
12.6.1 Contact Cardiac mapping systems
12.6.2 Non-contact Cardiac mapping systems
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cardiac Mapping Market Size Forecast by Applications
12.10.1 Atrial Fibrillation
12.10.2 Atrial Flutter
12.10.3 AVNRT
12.10.4 Other Arrhythmias
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cardiac Mapping Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cardiac Mapping Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cardiac Mapping Market Size Forecast by Type
13.6.1 Contact Cardiac mapping systems
13.6.2 Non-contact Cardiac mapping systems
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cardiac Mapping Market Size Forecast by Applications
13.10.1 Atrial Fibrillation
13.10.2 Atrial Flutter
13.10.3 AVNRT
13.10.4 Other Arrhythmias
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiac Mapping Market: Competitive Dashboard
14.2 Global Cardiac Mapping Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biosense Webster
14.3.2 Abbott
14.3.3 Boston Scientific Corporation
